EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

News provided by

Apr 16, 2013, 12:42 ET

NEW YORK, April 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

http://www.reportlinker.com/p01158447/EpiCast-Report-Psoriasis---Epidemiology-Forecast-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

Summary

Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes and of all ages and races/ethnicities. The global prevalence of psoriasis varies geographically, with the disease being more prevalent in the colder areas of the north, and less prevalent in the tropics and warmer regions of the world (Weller et al., 2008). In European countries, psoriasis is more prevalent in residents of the colder central regions and less prevalent in residents of the southern regions. In some Asian countries, such as India, the prevalence of psoriasis is highest in the northern parts of the country. In contrast to India, China shows no difference in prevalence between the northern and southern regions (Bedi, 1995; Ding et al., 2012; Kawada et al., 2003; Naldi et al., 2004; Saraceno et al., 2006). In addition to the north-to-south prevalence gradient observed within most countries, the prevalence of psoriasis also varies among different countries. Globally, the prevalence of psoriasis varies from as low as 0.03% in Japan to as high as 3.15% in the US (Ding et al., 2012; Kawada et al., 2003). Differences in the reported prevalence between countries may be attributable to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies (Bedi, 1995; Ding et al., 2012; Gelfand et al., 2005b).

Scope

- The Psoriasis EpiCast Report provides an overview of the risk factors and global trends of psoriasis in the nine major markets (the US, France, Germany, Italy, Spain, the UK, Japan, China, and India).
- It includes a 10-year epidemiology forecast of the prevalent cases of psoriasis segmented by sex and age (by five-year increments, beginning at age 15 years and ending at =85 years) in the 9MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
- Quantify patient populations in the global psoriasis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for psoriasis therapeutics in each of the markets covered.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Risk Factors and Comorbidities 8
3.1.1 Family history of psoriasis increases the risk of developing the disease by nearly 20 times 9
3.1.2 Obesity doubles the risk of psoriasis 9
3.1.3 Smoking, combined with other risk factors, increases the risk for psoriasis up to nine times 10
3.1.4 Psoriatic arthritis is present in up to 40.0% of all psoriasis patients 10
3.1.5 Nearly half of all psoriasis patients report elevated stress levels, depression, and thoughts of suicide 11
3.2 Global Trends 12
3.2.1 US 12
3.2.2 5EU 13
3.2.3 Japan 14
3.2.4 China 14
3.2.5 India 15
3.3 Forecast Methodology 15
3.3.1 Sources Used 16
3.3.2 Forecast Assumptions and Methods 19
3.3.3 Sources Not Used 22
3.4 Epidemiology Forecast (2012–2022) 23
3.4.1 Prevalent Cases of Psoriasis 23
3.4.2 Age-Specific Prevalent Cases of Psoriasis 25
3.4.3 Sex-Specific Prevalent Cases of Psoriasis 28
3.4.4 Age-Standardized Prevalence of Psoriasis 29
3.5 Discussion 30
3.5.1 Conclusions on Epidemiology Trends 30
3.5.2 Limitations of Analysis 31
3.5.3 Strengths of Analysis 32
4 Appendix 33
4.1 Bibliography 33
4.2 About the Authors 37
4.2.1 Epidemiologists 37
4.2.2 Reviewers 38
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 39
4.2.4 Global Head of Healthcare 39
4.3 About GlobalData 39
4.4 About EpiCast 40
4.5 Contact Us 40
4.6 Disclaimer 40

List of Tables

Table 1: Risk Factors and Comorbidities Associated with Psoriasis 8
Table 2: 9MM, Sources of Psoriasis Epidemiology Data Used for the Forecast 16
Table 3: 9MM, Prevalent Cases of Psoriasis, Ages ?15 Years, Men and Women, N, 2012–2022 24
Table 4: 9MM, Age-Specific Prevalent Cases of Psoriasis, Ages ?15 Years, Men and Women, N (Row %), 2012 26
Table 5: 9MM, Sex-Specific Prevalent Cases of Psoriasis, Ages ?15 Years, N (Row %), 2012 28

List of Figures

Figure 1: 9MM, Prevalent Cases of Psoriasis, Ages ?15 Years, Men and Women, N, 2012–2022 24
Figure 2: 9MM, Age-Specific Prevalent Cases of Psoriasis, Ages ?15 Years, Men and Women, N, 2012 27
Figure 3: 9MM, Sex-Specific Prevalent Cases of Psoriasis, Ages ?15 Years, N, 2012 29
Figure 4: 9MM, Age-Standardized Prevalence of Psoriasis, Ages ?15 Years, Men and Women, %, 2012 30

To order this report:
Pathology Industry: EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker